Aclaris Therapeutics

Aclaris Therapeutics, founded in the United States, is a biopharmaceutical company dedicated to developing innovative drugs and therapies for dermatology and immunology. Their core mission is to empower patients by translating scientific discoveries into practical treatments for immuno-inflammatory conditions. Aclaris focuses on addressing underserved medical needs through its specialized expertise in kinome innovation, aiming to provide effective solutions for patients across the U.S.

Notable figures associated with Aclaris include its leadership team and board members who bring extensive experience in pharmaceuticals and biotechnology. The company has attracted significant investment from prominent healthcare investors and has participated in major industry conferences like the Goldman Sachs Annual Global Healthcare Conference. Aclaris has achieved key milestones in drug development and commercialization, making a substantial impact on the treatment landscape for dermatological and immunological conditions.